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The ability of the tumor-promoting phorbol ester 4fl-phorbol 12fl-myristate 13,t-acetate (PMA) to induce protein kinase 
C (PKC) translocation a d lysosomal enzyme r lease was examined inskin fibroblasts from normal subjects and from 
patients with cystic fibrosis (CF). As compared tonormal fibroblasts, those CF exhibited: (i)an increased sensitivity o
the effect of PMA on the disappearance of PKC from cytosolic fractions as well as a greater and earlier ecovery, in
the membrane fraction, of the PKC activity lost in the cytosolic fraction; (ii) an earlier esponse toPMA for its effect 
on fl-N-acetylglucosaminidase release. In contrast, he inactive phorbol ester 4,t-phorbol 12,13-didecanoate (4atPDD) 
proved ineffective ininducing PKC translocation a d fl-N-acetylglucosaminidase release inboth normal and CF fibro- 
blasts. The data suggest a defect in the regulation ofPKC activity in CF fibroblasts, which may lead to altered secretion. 
Protein kinase C; Lysosomal enzyme r lease; Phorbol ester; Cystic fibrosis; (Skin fibroblast) 
1. INTRODUCTION 
Cystic fibrosis is an autosomal-recessive disease 
which is characterized as an exocrinopathy with 
disturbances in mucus secretion and electrolyte 
transport and which mainly affects epithelial cells. 
However, it has recently been shown that skin 
fibroblasts also exhibit the most common defect 
associated with this disease, i.e. decreased 
permeability to C1- [1], thus validating the use of 
this cell type as a model in investigations related to 
CF. 
Here, we have compared, in skin fibroblasts 
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from normal subjects and CF patients, the ability 
of  PKC, an enzyme which has been shown to play 
a key role in secretory processes [2], to be ex- 
ogenously activated. Taking advantage of the 
property of PMA of directly activating PKC by 
substituting for endogenous diacylglycerol, we 
thus evaluated in fibroblasts from both groups the 
ability of the phorbol ester to induce: (i) the 
translocation of PKC from cytosolic to membrane 
fractions, a process presumably associated with the 
activation of the enzyme [3,4]; and (ii) the release 
of  B-N-acetylglucosaminidase, a lysosomal 
glycoprotein abundantly secreted in the ex- 
tracellular space. 
Our results provide clear evidence that, in 
response to PMA, the CF fibroblasts (as compared 
to normal ones) exhibit: (i) increased sensitivity 
with respect to the disappearance of PKC from the 
cytosolic fraction, with no modification of the 
maximal responsiveness; (ii) greater and earlier 
recovery, in the membrane fraction, of the enzyme 
activity lost in the cytosolic fraction; (iii) earliel: 
release of B-N-acetylglucosaminidase. Taken 
together, these data demonstrate impairment of 
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the responses of CF fibroblasts to the phorbol  ester 
and suggest a defect in the regulation of PKC ac- 
tivity in these patients, leading to altered secretion. 
2. MATERIALS  AND METHODS 
2.1. Materials 
PMA, 4a, PDD, PMSF, PS, 1,2-diolein, ATP, histone (type 
III-S) and MLlB-2-acetamido-2-deoxy-B-D-glucopyranoside 
were purchased from Sigma (USA). DMEM was obtained from 
Flow Labs, DEAE-cellulose (DE-52) was from Pharmacia. 
[7-32p]ATP (30 Ci/mmol) was from New England Nuclear 
(Boston, MA). 
2.2. Cell culture and fractionation 
Cultures of human fibroblasts were established from skin 
biopsies performed on 5 control subjects and 3 CF patients. 
Cells were grown to confluence in DMEM supplemented with 
10070 (v/v) newborn calf serum, penicillin (250 mU/ml), strep- 
tomycin (250/~g/ml) and glutamine (5 mM). 48 h prior to use 
in an experiment, cells were serum-deprived. Immediately 
before the experiment, cells were washed 5times with serum- 
free DMEM and then incubated in this medium at 37°C, in 
either the absence or presence ofPMA or 4~ PDD which were 
prepared and used under the conditions described in [5]. 
Treatments were stopped by decanting the media and rinsing 
monolayers 5 times with ice-cold PBS. Cells were then scraped 
with a rubber policeman, suspended in 2 ml ice-cold buffer A 
[20 mM Tris-HCl (pH 7.5) at 4°C, 2 mM EDTA, 5 mM EGTA, 
0.25 M sucrose, 50 mM/~-mercaptoethanol] and subsequently 
homogenized via 20 strokes of a tight-fitting Teflon 
homogenizer. The homogenates were centrifuged at 105000 x
g. Supernates (cytosols) were decanted and the pellets uspend- 
ed in 1 ml buffer A containing 0.2 mM PMSF and 0.1 °70 Triton 
X-100. After 60 min at 4°C, the solubilized membranes were 
centrifuged as described above. As a purification step, cytosolic 
and membrane-solubilized fractions corresponding to 200/~g 
protein were applied to 0.5-ml columns of DE-52 cellulose 
which had been equilibrated in5 ml buffer B [20 mM Tris (pH 
7.4), 50 mMff-mercaptoethanol, 1 mM EGTA, 1 mM EDTA]. 
The columns were rinsed with 2-vols buffer B and then stepwise 
eluted with 2 column volumes of buffer B containing 0.05, 0.15 
and 0.5 M KCI. PKC activity was recovered inthe 0.05 M KCI 
fraction. Protein was determined by the Bradford ye method, 
using Bio-Rad reagent and BSA as the standard. 
2.3. PKC assay 
PKC activity was determined by slight modifications of 
previous methods [6,7]. The complete reaction mixture 
(0.25 ml) contained 5/~mol Tris-HCl (pH 7.5), 2.5 ,~mol Mg 
acetate, 25nmol [7-32p]ATP, 20#g PS, 5/~g 1,2-diolein, 
125 nmol CaCI2 (in excess of chelator concentration) and 50 #g 
histone III-S. Basal activity (Ca2+/PS-independent kinase ac- 
tivity) was determined by incubation of samples in the absence 
of PS, diolein and Ca 2+. Reactions were initiated by addition 
of the cellular extracts (10/~g protein) and terminated after 
5 min at 30°C as in [8]. PKC activity is expressed asthe activity 
(pmol 32p transferred to histone III-S/min per mg protein) 
measured in the presence of Ca 2+, PS and diolein minus the 
basal activity. 
2.4. ~-N-Acetylglucosaminidase release 
Confluent serum-deprived cells were incubated at 37°C in 
DMEM without or with PMA or 4a, PDD for different ime 
periods. At the end of each time period, the medium was 
assayed for basal and phorbol ester-induced ~'-N- 
acetylglucosaminidase release. The enzyme activity was 
measured fluorometrically, using MUB-2-acetamido-2-deoxy- 
~-D-glucopyranoside (4 mM suspended in 0.1 M citrate buffer, 
pH 4.6) as described [9]. 
2.5. Statistical analysis 
Where indicated, the differences between the mean values 
were evaluated by Student's t-test. 
3. RESULTS AND DISCUSSION 
• Fig. 1 shows the dose-response curves for the ef- 
fect of PMA on the disappearance of cytosolic 
PKC activity in normal  and CF fibroblasts. In nor- 
mal fibroblasts, PMA at 0.16-16 nM had no ef- 
fect on cytosolic PKC activity and a level of 
160 nM was required to decrease the enzyme ac- 
tivity by 45070. Similar results were reported by 
Halsey et al. [10] for 3T3 fibroblasts. In  contrast, 
in CF fibroblasts, a l inear decrease in cytosolic 
PKC activity was observed over the range 
0 .16-16nM,  which reached 54070 at 16nM.  
Moreover, at 160 nM PMA,  the decrease (72070) in 
PKC cytosolic activity of cells from CF subjects 
was 1.6-fold that elicited in the normal  ones 
(45°70). Thus, in CF fibroblasts, the dose-response 
curve for the effect of PMA on cytosolic PKC 
depletion exhibited a marked leftward shift as 
compared to that observed for normal  cells which 
was superimposable to that reported in [10]. 
However, as shown in f ig. l ,  no appreciable dif- 
ference was noted between control and CF 
fibroblasts when considering the maximal 
decreases in cytosolic PKC activity elicited by 
PMA (75 and 81070, respectively). On the other 
hand, the inactive phorbol ester 4a, PDD (1.6/zM) 
proved ineffective in inducing the disappearance of 
cytosolic PKC (9 and 7070 decreases in control and 
CF fibroblasts, respectively), which provides 
assessment of the specificity of the effect of PMA.  
Taken together, the present results clearly indicate 
that CF fibroblasts exhibit greater sensitivity than 
the normal  ones to the effect of PMA on the disap- 
pearance of cytosolic PKC, without any modif ica- 
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Fig.l. Dose-response curves for the effect of PMA on the 
disappearance of PKC activity from cytosolic fractions of 
normal and CF fibroblasts. Fibroblasts from normal and CF 
subjects were xposed for 6 rnin to the indicated concentrations 
of PMA. After cells had been rimed 5 times with ice-cold PBS, 
cytosolic extracts were prepared and assayed for PKC activity 
as described insection 2. Results are expressed aspercentage of 
control PKC activity (100%) which amounted to 156 + 14 and 
163:1:9 pmol 3Zp transferred to historic III-S/min per mg 
protein for normal and CF fibroblasts, respectively. Each point 
represents he mean + SE of quadruplicate d terminations. 
Data are from one representative experiment out of a series of 
3 experiments. 
tion of their maximal responsiveness to the 
phorbol ester. 
Fig.2 shows the time course of PKC transloca- 
tion from cytosolic to membrane fractions in nor- 
mal (fig.2A) and CF (fig.2B) fibroblasts maximally 
stimulated by PMA. In both cell lines, the time 
course of the effect of PMA on the disappearance 
of cytosolic PKC activity was roughly similar: the 
phorbol ester rapidly depleted the enzyme activity 
with a maximum observed at 6 min in cytosols 
from either normal or CF fibroblasts. By contrast, 
both cell lines markedly differed in the ability of  
their membrane fractions to recover the PKC ac- 
tivity lost in the cytosolic fractions..Thus, in nor- 
mal fibroblasts, the initial (measured at zero time) 
PKC activity of the membrane fractions remained 
unchanged for the first 2 min, whereas for those of 
CF, the initial membrane PKC activity exhibited a 
marked increase (217°70 over basal value) after only 
30 s exposure to PMA, which was the earliest ime 
tested. Moreover, whereas after 2 min exposure to 
PMA, the PKC activity was slowly recovered in the 
membrane fraction of normal fibroblasts and ex- 
hibited, after 6 min, a maximal increase of 102°70 
over the basal value, in CF fibroblasts, the 
membrane-bound PKC activity rapidly increased 
up to a maximum (also at 6 min) of 541°70 over the 
basal value. Such a difference between ormal and 
CF fibroblasts is accounted for by the data 
presented in fig.2C: after 6 min exposure of CF 
cells to PMA, their membrane fraction exhibited a
selective increase in PKC activity, without any 
modification of the basal kinase activity (Ca 2+/PS- 
independent kinase). In contrast, in the membrane 
fraction from normal cells, phorbol ester treat- 
ment produced, along with an increase in PKC ac- 
tivity, a 2.1-fold increase (p < 0.001) in 
CaZ+/PS-independent activity. A similar observa- 
tion has been reported for other systems [10,11]. 
This suggests that the PKC activity recovered in 
the membrane fraction of  normal ceils is pro- 
gressively converted to some extent into a 
Ca2+/PS-independent kinase, presumably through 
a proteolytic step. Of  interest in this regard is the 
finding reported in [12,13] that, once associated 
with,the membrane, PKC becomes usceptible to 
proteolysis, a process which is now believed to be 
the first step in the enzyme down-regulation 
[14,15]. In any case, the present results provide 
further evidence for a clear-cut difference in the 
responses exhibited by CF and normal fibroblasts 
to the effect of PMA on the subcellular redistribu- 
tion of PKC., 
Since PMA has been shown to induce, most 
probably through PKC activation, lysosomal en- 
zyme release [16], we next compared the e f fecto f  
the phorbolester on this process in normal and CF 
fibroblasts. We thus measured in both cell lines the 
time courses of PMA-induced release of /3-N- 
acetylglucosaminidase. In these experiments, the 
release of enzyme was measured in parallel at each 
time point in either the absence (basal values) or 
presence of PMA, the results being expressed as 
percentage increase-over corresponding basal 
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Fig.2. Time course of the effect of PMA on the subcellular PKC redistribution in normal and CF fibroblasts. Fibroblasts from normal 
(A) and CF (B) subjects were exposed to 1.6/~M PMA for the indicated times. After cells had been rinsed 5 times with ice-cold PBS, 
cytosolic and membrane fractions were prepared and assayed for PKC activity as described in section 2. 100% values of cytosolic and 
membrane PKC activity are given in panel C which details the calculation of the enzyme activity at time zero (control, i.e. 100%) and 
after 6 rain exposure to PMA. Each bar represents the kinase activity measured in the presence (open bars) or absence (dotted bars) 
of Ca 2+, PS and 1,2-diolein. The hatched bar refers to the difference between the two conditions, i.e. PKC activity. Data are means + 
SE of 3 (CF) or 5 (normal) experiments performed in quadruplicate. 
values. This methodologica l  approach was design- 
ed to obviate the incidence o f  spontaneous secre- 
t ion o f  ~-N-acety lg lucosaminidase which has been 
shown to increase linearly as a funct ion o f  t ime 
[17]. As shown in f ig.3, PMA- induced H-N- 
acetylglucosaminidase r lease occurred earlier in 
CF  f ibroblasts than in the normal  ones. After only 
2 min  exposure o f  CF f ibroblasts to PMA,  a 75°70 
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Fig.3. Time course of the effect of PMA on the release offl-N- 
acetylglucosaminidase by normal and CF fibroblasts. 
Fibroblasts from normal and CF subjects were incubated at 
37°C in the absence or presence of 0.16/~M PMA. At the 
indicated times, the amount of /Y-N-acetylglucosaminidase 
released into the medium was measured as described in section 
2. Results are expressed as the percent increase induced by PMA 
over the respective basal values (i.e. in the absence of PMA) 
which were determined in parallel at each time point. These 
basal values ranged from 1~ to 19 nmol/h per ml medium for 
both normal and CF fibroblasts. Each point is the mean + SE 
of 3 determinations. Data are from a representative experiment 
which was repeated twice. 
on lysosomal enzyme release. Thus, our data show 
that, in CF fibroblasts, the PMA-induced release 
of/3-N-acetylglucosaminidase w  more rapid but 
not greater than that elicited in normal cells. This 
observation is consistent with the finding that the 
membrane-bound PKC, i.e. the active form of the 
enzyme, increased much more rapidly in CF 
fibroblasts than in normal cells. Also, the fact that 
no effect of PMA on/3-N-acetylglucosaminidase 
release could be observed in normal ceils before a 
6 min exposure to the phorbol ester most probably 
reflects the slow appearance of membrane-bound 
PKC in these cells. Thus, the effects of PMA on 
the processes of PKC redistribution and lysosomal 
enzyme release appeared to be related, in both nor- 
mal and CF fibroblasts. 
In conclusion, we report here for the first time 
that CF fibroblasts behave quite differently from 
the normal cells with respect to their ability to res- 
pond to PMA in its effect on PKC translocation as
well as lysosomal enzyme release. Our data suggest 
a defect in the regulation of PKC in CF 
fibroblasts, leading to altered release reactions. 
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increase in enzyme release was observed which re- 
mained roughly constant hroughout he time 
period studied. By contrast, in normal fibroblasts, 
a latency period of 6 min was observed before an 
effect of PMA could be seen. Nevertheless, the 
PMA-induced increase in /3-N-aceteylgluco- 
saminidase r lease that was observed 10 min after 
normal cells were exposed to PMA (110 + 11070 
over basal evel) was slightly but not significantly 
higher than that measured inthe CF ones (78 ± 4°70 
over basal evel) after the same time period. On the 
other hand, at any time point considered, 4c~PDD 
(1.6/zM) failed to elicit significant modification of 
~-N-acetylglucosaminidase release in either normal 
or CF fibroblasts (109 _+ 10 and 102 + 8°70 of 
respective basal values). This finding, which agrees 
with results reported elsewhere [16] provides an 
assessment of the specificity of the effect of PMA 
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